logo

For the Inventor, By the Inventor

Kanagawa, Japan

Oncotherapy Science, Incorporated


USPTO Granted Patents = 148



Forward Citations = 354

Loading Chart...
Loading Chart...

83 inventors (with patents filed for the assignee):

goldMedal Takuya Tsunoda (73 out of 73 patents)

silverMedal Yusuke Nakamura (54 out of 111 patents)

bronzeMedal Yusuke Nakamura (34 out of 65 patents)

4.  Shuichi Nakatsuru (33 out of 33 patents)

5.  Sachiko Yoshimura (32 out of 32 patents)

6.  Tomohisa Watanabe (30 out of 30 patents)

7.  Ryuji Ohsawa (28 out of 28 patents)

8.  Ryuji Osawa (27 out of 27 patents)

9.  Toyomasa Katagiri (22 out of 22 patents)

10.  Yasuharu Nishimura (19 out of 22 patents)

11.  Yoichi Furukawa (17 out of 19 patents)

12.  Hideaki Tahara (14 out of 17 patents)

13.  Yataro Daigo (11 out of 11 patents)

14.  Sachiko Yamashita (9 out of 9 patents)

15.  Tetsuro Hikichi (9 out of 9 patents)


Core Competencies:
Peptide Vaccines
Monoclonal Antibodies
Cancer Treatment
Tumor-Associated Antigens
Immune Response Induction
Lymphocyte Engineering
Epitope Peptides
Pharmaceutical Compositions
Cancer Immunotherapy
Vaccine Development
Polypeptides
Targeted Therapies

148 patents:

1. 12195559 - CDCA1-derived peptide and vaccine containing same (2025-01-14),
2. 11673915 - DEPDC1-derived peptide and vaccine containing same (2023-06-13),
3. 11598780 - Engineering lymphocytes with specific alpha and beta chains on their t-cell receptor (2023-03-07),
4. 11547723 - KOC1-derived peptide and vaccine including same (2023-01-10),
5. 11266729 - UBE2T peptides and vaccines containing the same (2022-03-08),
6. 11242365 - FOXM1-derived peptide, and vaccine including same (2022-02-08),
7. 11091517 - Peptide derivative and pharmaceutical composition containing same (2021-08-17),
8. 11079386 - Monoclonal antibody against FZD10 and use thereof (2021-08-03),
9. 11066477 - Monoclonal antibody against MELK and utilization thereof (2021-07-20),
10. 10793599 - MPHOSPH1-derived peptide, and vaccine including same (2020-10-06),
11. 10711047 - CDCA1 epitope peptides and vaccines containing the same (2020-07-14),
12. 10676514 - CDCA1-derived peptide and vaccine containing same (2020-06-09),
13. 10676508 - DEPDC1-derived peptide and vaccine containing same (2020-06-09),
14. 10669310 - Peptide for cancer treatment and pharmaceutical composition containing same (2020-06-02),
15. 10597431 - NEIL3 peptides and vaccines including the same (2020-03-24),
Oncotherapy Science, Incorporated is a biotechnology company focused on researching and developing innovative cancer therapies. With a team of expert scientists and researchers, the company aims to discover novel treatment approaches that can improve patient outcomes in various types of cancer. Oncotherapy Science collaborates with leading academic institutions and industry partners to advance scientific knowledge and translate discoveries into effective therapies. Their dedication to precision medicine and personalized cancer treatment drives their mission to make a meaningful impact in the field of oncology.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

...
148 Patents

#22 in Kanagawa

#843 in Japan

#5,377 in the World

...
Kanagawa, Japan

Oncotherapy Science, Incorporated

Forward Citations = 354

83 inventors:

goldMedal Takuya Tsunoda (73 out of 73 patents)

silverMedal Yusuke Nakamura (54 out of 111 patents)

bronzeMedal Yusuke Nakamura (34 out of 65 patents)

4.  Shuichi Nakatsuru (33 out of 33 patents)

5.  Sachiko Yoshimura (32 out of 32 patents)

Please report any incorrect information to support@idiyas.com
Loading…